Anticoagulation therapy with combined low dose aspirin and warfarin following mechanical heart valve replacement

Thrombosis Research

Volumn 128, Issue 5, 2011, Pages

  Dong, Ming Feng ^a,b   Ma, Zeng Shan ^a,b,d   Ma, Sheng Jun ^a,b   Chai, Shou Dong ^a,b   Tang, Pei Zhe ^a,b   Yao, Dao Kuo ^c   Wang, Le Xin ^a,b,d  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b TAISHAN MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d CHARLES STURT UNIVERSITY   (Australia)

Author keywords

anticoagulation; aspirin; hemorrhage; mechanical valve replacement; thromboembolic event; warfarin

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART VALVE REPLACEMENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MECHANICAL HEART VALVE REPLACEMENT; MORTALITY; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; THROMBOEMBOLISM; THROMBOSIS;

ADULT; ANTICOAGULANTS; ASPIRIN; DRUG THERAPY, COMBINATION; DRUG TOXICITY; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PROTHROMBIN TIME; THROMBOEMBOLISM; TREATMENT OUTCOME; WARFARIN; YOUNG ADULT;

EID: 80055064850     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.07.006     Document Type: Article

References (22)

1. V.T. Nkomo, J.M. Gardin, T.N. Skelton, J.S. Gottdiener, C.G. Scott, and M. Enriquez-Sarano Burden of valvular heart diseases: a population-based study Lancet 368 9540 2006 1005 1011 (Pubitemid 44353666)
2. R.O. Bonow, B.A. Carabello, K. Chatterjee, A.C. de Leon Jr., D.P. Faxon, and M.D. Freed ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons J Am Coll Cardiol 48 3 2006 e1 e148 (Pubitemid 44109952)
3. D. Hering, C. Piper, R. Bergemann, C. Hillenbach, M. Dahm, and C. Huth Thromboembolic and bleeding complications following St. Jude Medical valve replacement: results of the German Experience With Low-Intensity Anticoagulation Study Chest 127 1 2005 53 59 (Pubitemid 41724555)
4. L.H. Edmunds Jr. Thrombotic and bleeding complications of prosthetic heart valves Ann Thorac Surg 44 4 1987 430 445 (Pubitemid 17159745)
5. A. Russo, F. Grigioni, J.F. Avierinos, W.K. Freeman, R. Suri, and H. Michelena Thromboembolic complications after surgical correction of mitral regurgitation incidence, predictors, and clinical implications J Am Coll Cardiol 51 12 2008 1203 1211 (Pubitemid 351382093)
6. E.G. Butchart, C. Gohlke-Barwolf, M.J. Antunes, P. Tornos, R. De Caterina, and B. Cormier Recommendations for the management of patients after heart valve surgery Eur Heart J 26 22 2005 2463 2471 (Pubitemid 41552977)
7. D.N. Salem, P.T. O'Gara, C. Madias, and S.G. Pauker Valvular and structural heart disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 6 Suppl. 2008 593S 629S (Pubitemid 351892973)
8. A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, and G. Filippatos Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 28 2 2007 230 268 (Pubitemid 46276943)
9. A.G. Turpie, M. Gent, A. Laupacis, Y. Latour, J. Gunstensen, and F. Basile A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement N Engl J Med 329 8 1993 524 529 (Pubitemid 23232620)
10. J.C. Cappelleri, L.D. Fiore, M.T. Brophy, D. Deykin, and J. Lau Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart-valve replacement: a metaanalysis Am Heart J 130 3 Pt 1 1995 547 552
11. R.J. Larson, and E.S. Fisher Should aspirin be continued in patients started on warfarin? J Gen Intern Med 19 8 2004 879 886
12. F. Dentali, J.D. Douketis, W. Lim, and M. Crowther Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials Arch Intern Med 167 2 2007 117 124 (Pubitemid 46148058)
13. D. Massel, and S.H. Little Risks and benefits of adding anti-platelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis J Am Coll Cardiol 37 2 2001 569 578
14. J.H. You, F.W. Chan, R.S. Wong, and G. Cheng Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? Br J Clin Pharmacol 59 5 2005 582 587 (Pubitemid 40632249)
15. A.K. Pedersen, and G.A. FitzGerald Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing Clin Pharmacol Ther 37 1 1985 36 42 (Pubitemid 16225164)
16. M. Lordkipanidzé, C. Pharand, E. Schampaert, J. Turgeon, D.A. Palisaitis, and J.G. Diodati A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease Eur Heart J 28 14 2007 1702 1708 (Pubitemid 47227104)
17. M. Hurlen, M. Abdelnoor, P. Smith, J. Erikssen, and H. Arnesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 13 2002 969 974
18. R.F. Van Es, J.J. Jonker, F.W. Verheugt, J.W. Deckers, and D.E. Grobbee Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial Lancet 360 9327 2002 109 113 (Pubitemid 34786198)
19. A. Lanas, J. Fuentes, R. Benito, P. Serrano, E. Bajador, and R. Sainz Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin Aliment Pharmacol Ther 16 4 2002 779 786 (Pubitemid 34407526)
20. L. Hansson, A. Zanchetti, S.G. Carruthers, B. Dahlof, D. Elmfeldt, and S. Julius Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial Lancet 351 9118 1998 1755 1762 (Pubitemid 28269185)
21. R.G. Hart, L.A. Pearce, R. McBride, R.M. Rothbart, and R.W. Asinger Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation. Analysis of 2012 participants in the SPAF I-III clinical trials Stroke 30 6 1999 1223 1229 (Pubitemid 29259178)
22. J. Hirsh, E.W. Salzman, L. Harker, V. Fuster, J.E. Dalen, and J.A. Cairns Aspirin and other platelet active drugs: relationship among dose, effectiveness and side effects Chest 95 Suppl. 1989 12S 18S (Pubitemid 19045152)